JP2016508487A5 - - Google Patents

Download PDF

Info

Publication number
JP2016508487A5
JP2016508487A5 JP2015555384A JP2015555384A JP2016508487A5 JP 2016508487 A5 JP2016508487 A5 JP 2016508487A5 JP 2015555384 A JP2015555384 A JP 2015555384A JP 2015555384 A JP2015555384 A JP 2015555384A JP 2016508487 A5 JP2016508487 A5 JP 2016508487A5
Authority
JP
Japan
Prior art keywords
phenyl
naphthyridin
hydrazinecarbonyl
ethynyl
biphenyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2015555384A
Other languages
English (en)
Japanese (ja)
Other versions
JP2016508487A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2014/013204 external-priority patent/WO2014117090A1/en
Publication of JP2016508487A publication Critical patent/JP2016508487A/ja
Publication of JP2016508487A5 publication Critical patent/JP2016508487A5/ja
Pending legal-status Critical Current

Links

JP2015555384A 2013-01-28 2014-01-27 金属酵素阻害剤化合物 Pending JP2016508487A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361757594P 2013-01-28 2013-01-28
US61/757,594 2013-01-28
PCT/US2014/013204 WO2014117090A1 (en) 2013-01-28 2014-01-27 Metalloenzyme inhibitor compounds

Publications (2)

Publication Number Publication Date
JP2016508487A JP2016508487A (ja) 2016-03-22
JP2016508487A5 true JP2016508487A5 (enExample) 2017-03-02

Family

ID=51228112

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2015555384A Pending JP2016508487A (ja) 2013-01-28 2014-01-27 金属酵素阻害剤化合物

Country Status (6)

Country Link
US (1) US9663488B2 (enExample)
EP (1) EP2948450A4 (enExample)
JP (1) JP2016508487A (enExample)
AU (1) AU2014209107B2 (enExample)
CA (1) CA2898615A1 (enExample)
WO (1) WO2014117090A1 (enExample)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10221160B2 (en) 2012-01-20 2019-03-05 Mycovia Pharmaceuticals, Inc. Metalloenzyme inhibitor compounds
ES2800905T3 (es) 2014-03-19 2021-01-05 Mycovia Pharmaceuticals Inc Procedimiento para compuesto antifúngico
EP3119755B1 (en) 2014-03-19 2019-03-06 Viamet Pharmaceuticals (NC), Inc. Antifungal compound process
ES2815373T3 (es) 2014-03-19 2021-03-29 Mycovia Pharmaceuticals Inc Procedimiento de compuesto antifúngico
CN106103424A (zh) 2014-03-19 2016-11-09 维亚梅特制药公司 2‑(2,4‑二氟苯基)‑1,1‑二氟‑1‑(5‑经取代的吡啶‑2‑基)‑3‑(1h‑四唑‑1‑基)丙烷‑2‑醇和其制备方法
US10017494B2 (en) 2014-03-19 2018-07-10 Mycovia Pharmaceuticals, Inc. Antifungal compound process
US10399943B2 (en) 2014-03-19 2019-09-03 Mycovia Pharmaceuticals, Inc. Antifungal compound process
MX2016012060A (es) 2014-03-19 2017-01-19 Viamet Pharmaceuticals Inc 2-(2,4-difluorofenil)-1,1-difluoro-1-(5-sustituido-piridin-2-il)- 3-(1h-tetrazol-1-il)propan-2-oles y procesos para su preparacion.
US10196375B2 (en) 2014-03-19 2019-02-05 Mycovia Pharmaceuticals, Inc. Antifungal compound process
CA2942932A1 (en) 2014-03-19 2015-09-24 Viamet Pharmaceuticals, Inc. Antifungal compound process
JP6618530B2 (ja) 2014-09-09 2019-12-11 バイエル ファーマ アクチエンゲゼルシャフト 置換n,2−ジアリールキノリン−4−カルボキサミドおよび抗炎症剤としてのその使用
JP6899323B2 (ja) 2014-10-14 2021-07-07 ラ ホーヤ インスティテュート オブ アレルギー アンド イミュノロジー 低分子量タンパク質チロシンホスファターゼの阻害剤、及びその使用
WO2016146602A1 (de) * 2015-03-18 2016-09-22 Bayer Pharma Aktiengesellschaft Substituierte n-bicyclo-2-arylchinolin-4-carboxamide und ihre verwendung
EA037521B1 (ru) 2015-09-18 2021-04-07 ВиПиЭс-3, ИНК. Противогрибковые соединения и способы их получения
CN105272896A (zh) * 2015-10-19 2016-01-27 山东国润生物医药有限公司 ((2s)-2-氮丙啶基)二苯基甲醇的制备方法
US10611747B2 (en) 2015-11-09 2020-04-07 Forge Therapeutics, Inc. Pyrone based compounds for treating bacterial infections
US10414735B2 (en) 2015-11-09 2019-09-17 Forge Therapeutics, Inc. Substituted hydroxypyrimidinones for treating bacterial infections
WO2017153234A1 (de) 2016-03-09 2017-09-14 Bayer Pharma Aktiengesellschaft Substituierte n-cyclo-2-arylchinolin-4-carboxamide und ihre verwendung
WO2017153235A1 (de) 2016-03-09 2017-09-14 Bayer Pharma Aktiengesellschaft Substituierte n-cyclo-3-aryl-1-naphthamide und ihre verwendung
WO2017153231A1 (de) 2016-03-09 2017-09-14 Bayer Pharma Aktiengesellschaft Substituierte n-cyclo-2-arylisochinolinon-4-carboxamide und ihre verwendung
JP2019142776A (ja) * 2016-06-24 2019-08-29 石原産業株式会社 N−(4−ピリジル)ベンズアミド化合物又はその塩を有効成分として含有する有害生物防除剤
CN114989205A (zh) 2016-12-22 2022-09-02 卡里塞拉生物科学股份公司 用于抑制精氨酸酶活性的组合物和方法
PH12019502314A1 (en) 2017-04-10 2020-10-26 Bayer Ag Substituted n-arylethyl-2-arylquinoline-4-carboxamides and use thereof
TWI770157B (zh) 2017-04-10 2022-07-11 德商拜耳廠股份有限公司 經取代之n-芳基乙基-2-胺基喹啉-4-甲醯胺及其用途
WO2018204176A1 (en) 2017-05-01 2018-11-08 Sanford Burnham Prebys Medical Discovery Institute Inhibitors of low molecular weight protein tyrosine phosphatase (lmptp) and uses thereof
US11021471B2 (en) 2017-05-10 2021-06-01 Forge Therapeutics, Inc. Antibacterial compounds
EP4438042A3 (en) * 2018-06-22 2024-12-04 Ohio State Innovation Foundation Methods and compositions for inhibition of dihydroorotate dehydrogenase
AU2019345150A1 (en) 2018-09-20 2021-05-13 Blacksmith Medicines, Inc. Antibacterial compounds
CN109456205B (zh) * 2018-12-17 2021-09-21 石河子大学 以取代喹啉或异喹啉酰肼吡啶-n-氧化物为配体的水相体系中的n-芳基化方法
EP3725788A1 (en) * 2019-04-15 2020-10-21 Bayer AG Novel heteroaryl-substituted aminoalkyl azole compounds as pesticides
WO2021195260A1 (en) 2020-03-25 2021-09-30 Forge Therapeutics, Inc. Lpxc inhibitor and methods of making
JP2024536864A (ja) 2021-09-28 2024-10-08 ブラックスミス メディシンズ,インク. Lpxc阻害剤およびその使用
WO2023219456A1 (ko) * 2022-05-12 2023-11-16 숙명여자대학교 산학협력단 퀴놀린 계열 히스톤디아세틸화 효소 저해활성물질, 이의 제조방법 및 이를 유효성분으로 포함하는 약학적 조성물
WO2023231964A1 (zh) * 2022-05-30 2023-12-07 赛诺哈勃药业(成都)有限公司 四氢萘啶衍生物在制备防治粘连相关疾病的药物中的应用

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA845594B (en) * 1983-07-22 1986-03-26 Du Pont Phenylquinolinecarboxylic acids and derivatives as antitumor agents
US4968702A (en) * 1989-01-17 1990-11-06 American Cyanamid Company Substituted quinolinecarboxylic acids
JPH083163A (ja) * 1994-06-22 1996-01-09 Kyowa Hakko Kogyo Co Ltd 縮合ピリジン誘導体
AU4007900A (en) * 1999-03-11 2000-10-16 Neurogen Corporation Aryl fused 2,4-disubstituted pyridines: nk3 receptor ligands
WO2001024785A2 (en) * 1999-10-01 2001-04-12 Institute Of Molecular And Cell Biology Dihydroorotate dehydrogenase inhibitors for the treatment of viral-mediated diseases
US6828329B2 (en) * 2000-06-26 2004-12-07 Neurogen Corporation Aryl fused substituted 4-oxy-pyridines
JP2004506038A (ja) * 2000-08-16 2004-02-26 ニューロゲン コーポレイション 2,4−置換ピリジン誘導体
US20040110802A1 (en) * 2002-08-23 2004-06-10 Atli Thorarensen Antibacterial benzoic acid derivatives
CA2540342A1 (en) * 2003-10-31 2005-05-12 Neurogen Corporation 4-amino (aza) quinoline derivatives as capsaicin receptor agonists
MXPA06006532A (es) * 2003-12-09 2006-08-23 Vertex Pharma Derivados de naftiridina y su uso como moduladores de receptores muscarinicos.
WO2006034512A2 (en) * 2004-09-23 2006-03-30 Bayer Pharmaceuticals Corporation Phenyl-substituted quinoline and quinazoline compounds for the treatment of diabetes
JP2009528289A (ja) * 2006-02-27 2009-08-06 ミシャロウ、アレクサンダー 対抗適応を誘発することにより神経伝達物質系を調節する方法
JP5227304B2 (ja) 2007-02-28 2013-07-03 大正製薬株式会社 新規なヒドロキサム酸誘導体
CN101084895B (zh) * 2007-06-22 2011-11-23 复旦大学 一种葡萄球菌色氨酰-tRNA合成酶抑制剂
JP2011517313A (ja) * 2007-12-11 2011-06-02 ビアメト ファーマシューティカルズ,インク. 金属結合部分を標的化部分と組み合わせて使用する金属酵素阻害剤
WO2010024356A1 (ja) * 2008-08-27 2010-03-04 大正製薬株式会社 ナフチリジン-n-オキシドを有する新規ヒドロキサム酸誘導体
WO2010094009A2 (en) * 2009-02-13 2010-08-19 Children's Hospital Medical Center Methods and compositions for the treatment of ras associated disorders
CA2785898C (en) * 2009-12-31 2018-07-03 Viamet Pharmaceuticals, Inc. Metalloenzyme inhibitor compounds
RU2450025C2 (ru) * 2010-07-16 2012-05-10 Учреждение Российской академии наук Институт высокомолекулярных соединений РАН МЕТАЛЛ-ПОЛИМЕРНЫЙ КОМПЛЕКС ЕВРОПИЯ (Eu3+) И (СО)ПОЛИ-(МЕТИЛМЕТАКРИЛАТ)-(1-МЕТАКРИЛОИЛ-2-(2-ПИРИДИЛ)-4-КАРБОКСИХИНОЛИЛ)ГИДРАЗИНА
BR112013014484A2 (pt) * 2010-12-13 2016-07-19 Viamet Pharmaceuticals Inc compostos inibidores de metaloenzimas
CN103492368A (zh) * 2011-04-08 2014-01-01 辉瑞大药厂 用作抗菌剂的咪唑、吡唑和噻唑衍生物
EP2721023B1 (en) * 2011-06-19 2018-08-08 Viamet Pharmaceuticals (NC), Inc. Metalloenzyme inhibitor compounds
EP2847168A1 (en) * 2012-05-10 2015-03-18 Achaogen, Inc. Antibacterial agents

Similar Documents

Publication Publication Date Title
JP2016508487A5 (enExample)
JP2014517068A5 (enExample)
US11247981B2 (en) Metalloenzyme inhibitor compounds
US9663488B2 (en) Metalloenzyme inhibitor compounds
JP6085613B2 (ja) 金属酵素阻害薬化合物
JP5828343B2 (ja) 金属酵素阻害化合物
US11040034B2 (en) Metalloenzyme inhibitor compounds
JP2016526535A5 (enExample)
JP2014517069A5 (enExample)
JP2013516418A (ja) 金属酵素阻害化合物
NZ609955A (en) Sgc stimulators
RU2010107892A (ru) Производные феноксипирролидина, их применение и фармацевтические композиции, содержащие их
TW200408390A (en) Hetero biaryl derivatives as matrix metalloproteinase inhibitors
JP2014525442A5 (enExample)
JP6071897B2 (ja) 金属酵素阻害化合物
JP2011524362A5 (enExample)
WO2003051906A2 (en) Compounds and methods
JP2019531317A5 (enExample)
Ganai Cell pathway include the duplication of its DNA and some of its organelles, the partitioning of its cytoplasm, chromosomes and other components into two daughter cells Menu